Home › Funds › Vanguard Group › CGON
Vanguard Group position in CGON
CG ONCOLOGY INC · Health Care
Latest position (Q4 2025)6.54M sh
Reported value held$271.52M
Portfolio Weight0.00%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.23M | $97.68M | New |
| Q2 2024 | 2.24M | $70.85M | Add |
| Q3 2024 | 5.08M | $191.72M | Add |
| Q4 2024 | 5.86M | $168.10M | Add |
| Q1 2025 | 5.84M | $142.93M | Hold |
| Q2 2025 | 5.91M | $153.57M | Add |
| Q3 2025 | 6.58M | $264.93M | Add |
| Q4 2025 | 6.54M | $271.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CGON
- BlackRock Inc 6.26M sh · $444.51M · Q2 2026
- Wellington Management Group 5.32M sh · $378.32M · Q2 2026
- Fidelity Management & Research (FMR) 4.16M sh · $295.67M · Q2 2026
- Geode Capital Management 2.15M sh · $153.02M · Q2 2026
- Franklin Resources 1.31M sh · $93.28M · Q2 2026
- Morgan Stanley 1.18M sh · $83.63M · Q2 2026
- Bank of America Corp 984.92K sh · $69.98M · Q2 2026
- UBS Group AG 977.70K sh · $69.47M · Q2 2026
- Goldman Sachs Group 857.71K sh · $60.94M · Q2 2026
- Northern Trust Corp 677.91K sh · $48.17M · Q2 2026
- Charles Schwab Investment Management 627.18K sh · $44.56M · Q2 2026